• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE FLEX W/SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE FLEX W/SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number PED2-400-20
Medical Device Problem Codes Material Deformation (2976); Activation Failure (3270)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/19/2026
Type of Reportable Event Malfunction
Event or Problem Description
Medtronic received a report that the patient was undergoing treatment for a saccular, unruptured c6 segment aneurysm with a max diameter of 5 mm and a 6 mm neck diameter.The landing zone was 3.56 mm distally and 4.1 mm proximally.It was noted that the patient's vessel tortuosity was mild.The access vessel was the femoral artery, with 7.2mm diameter.Dual antiplatelet treatment (dapt) was administered.The pru level was unknown.It was reported that by following standard procedure, the operator advanced the phenom27 catheter to the distal m1 segment.A ped2-4-20 stent was then delivered.After the stent was positioned, the microcatheter was withdrawn approximately 15 mm, at which point the distal end of the stent failed to open properly.The operator subsequently followed the standard procedural steps to resheath and attempt redeployment.Although the distal portion of the stent partially opened, it could not be fully deployed.It was suspected that the distal end of the stent might have been damaged.The stent was then removed from the body, and inspection confirmed damage to the distal end, preventing full expansion.The device was replaced with a ped2-3.75-25 stent, which was successfully deployed on the first attempt, and the procedure was completed uneventfully.The angiographic result post procedure was normal.It was unknown if the pipeline used for an indication that is not approved (off-label).The reported device and any accessory devices were prepared as indicated in the instructions for use (ifu).No patient symptoms or complications were associated with this event.Ancillary devices include a achieva medical guide catheter, stryker guidewire.
 
Additional Manufacturer Narrative
Continuation of d10: product id fg15150-0615-1s (lot: 232045494); implant date n/a; explant date n/a.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Additional information was received reporting that no causes or contributing factors for the damage were identified.No friction or difficulty during delivery or positioning.The pipeline had not been placed in a vessel bend when it failed to open.No additional steps or other devices were attempted to open the pipeline beside resheathing.The stent damage was observed as, "damage to the distal structure." no obvious abnormalities were observed with the p27.
 
Additional Manufacturer Narrative
H3: analysis results were not available as of the date of this report.A follow-up report will be submitted when analysis is complete.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE FLEX W/SHIELD TECHNOLOGY
Common Device Name
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
justin ellis
9775 toledo way
irvine, CA 92618
7635265677
MDR Report Key24663115
Report Number2029214-2026-00498
Device Sequence Number18463967
Product Code OUT
UDI-Device Identifier00763000449209
UDI-Public(01)00763000449209(17)280701(10)D049316
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
P100018
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Device Explanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 05/28/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberPED2-400-20
Device Catalogue NumberPED2-400-20
Device Lot NumberD049316
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/19/2026
Supplement Date Received by Manufacturer03/25/2026
05/01/2026
Initial Report FDA Received Date03/23/2026
Supplement Report FDA Received Date04/22/2026
05/28/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/02/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11...
Patient SexMale
-
-